TruBridge, Inc. (TBRG)
Jul 9, 2026 - TBRG was delisted (reason: acquired by IKS Health)
26.24
0.00 (0.00%)
Inactive · Last trade price on Jul 8, 2026
TruBridge Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 345.9 | 346.84 | 342.21 | 336.96 | 326.65 | 280.63 | |
Revenue Growth | 0.18% | 1.35% | 1.55% | 3.16% | 16.40% | 6.10% |
Cost of Revenue | 161.81 | 162.97 | 168.92 | 175.56 | 166.54 | 135.78 |
Gross Profit | 184.09 | 183.86 | 173.29 | 161.4 | 160.11 | 144.85 |
Selling, General & Admin | 104.97 | 99.9 | 95.8 | 103.68 | 77.59 | 69.56 |
Research & Development | 31.76 | 32.56 | 35.45 | 38.83 | 31.9 | 32.81 |
Amortization of Goodwill & Intangibles | 25.66 | 25.19 | 24.32 | 24.38 | 20.89 | 14.72 |
Operating Expenses | 163.46 | 158.73 | 156.91 | 168.83 | 132.82 | 119.24 |
Operating Income | 20.63 | 25.13 | 16.37 | -7.43 | 27.29 | 25.61 |
Interest Expense | -11.56 | -12.32 | -16.17 | -12.52 | -6.32 | -3.16 |
Other Non Operating Income (Expenses) | 0.42 | 0.41 | 0.32 | 0.75 | 1.62 | 1.53 |
EBT Excluding Unusual Items | 9.48 | 13.22 | 0.52 | -19.21 | 22.59 | 23.98 |
Merger & Restructuring Charges | -4.9 | -4.3 | -7.1 | - | - | -0.9 |
Impairment of Goodwill | - | - | - | -35.91 | - | - |
Gain (Loss) on Sale of Assets | -0.05 | -0.05 | -1.53 | - | - | - |
Asset Writedown | - | - | -3.4 | -2.34 | - | - |
Other Unusual Items | -5 | -5 | 1.04 | - | -4.5 | - |
Pretax Income | -0.47 | 3.87 | -10.47 | -57.46 | 18.08 | 23.08 |
Income Tax Expense | -4.87 | -0.49 | 10.48 | -9.33 | 2.21 | 4.65 |
Net Income | 4.4 | 4.35 | -20.95 | -48.13 | 15.87 | 18.43 |
Preferred Dividends & Other Adjustments | 0.14 | 0.15 | -0.79 | -1.08 | 0.31 | 0.41 |
Net Income to Common | 4.26 | 4.21 | -20.16 | -47.05 | 15.56 | 18.02 |
Net Income Growth | - | - | - | - | -13.68% | 30.43% |
Shares Outstanding (Basic) | 15 | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 15 | 14 | 14 | 14 | 14 | 14 |
Shares Change | 1.41% | 1.31% | 0.80% | -1.18% | 0.27% | 1.99% |
EPS (Basic) | 0.29 | 0.29 | -1.41 | -3.32 | 1.08 | 1.26 |
EPS (Diluted) | 0.29 | 0.29 | -1.41 | -3.32 | 1.08 | 1.26 |
EPS Growth | - | - | - | - | -14.29% | 28.57% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 44.62 | 35.65 | 29.5 | -0.87 | 32.11 | 46.82 |
Free Cash Flow Per Share | 3.07 | 2.46 | 2.06 | -0.06 | 2.24 | 3.27 |
Gross Margin | 53.22% | 53.01% | 50.64% | 47.90% | 49.02% | 51.62% |
Operating Margin | 5.96% | 7.25% | 4.78% | -2.21% | 8.35% | 9.13% |
Profit Margin | 1.23% | 1.21% | -5.89% | -13.96% | 4.76% | 6.42% |
Free Cash Flow Margin | 12.90% | 10.28% | 8.62% | -0.26% | 9.83% | 16.68% |
EBITDA | 33.82 | 38.41 | 30.22 | 10.94 | 47.13 | 41.55 |
EBITDA Margin | 9.78% | 11.08% | 8.83% | 3.25% | 14.43% | 14.81% |
D&A For EBITDA | 13.19 | 13.28 | 13.85 | 18.37 | 19.85 | 15.94 |
EBIT | 20.63 | 25.13 | 16.37 | -7.43 | 27.29 | 25.61 |
EBIT Margin | 5.96% | 7.25% | 4.78% | -2.21% | 8.35% | 9.13% |
Effective Tax Rate | - | - | - | - | 12.25% | 20.13% |
Revenue as Reported | 345.9 | 346.84 | 342.21 | 336.96 | 326.65 | 280.63 |